Validation Study of SCALA, Scale for Lateropulsion

Launched by UNIVERSITY HOSPITAL, GRENOBLE · Mar 6, 2017

Keywords

ClinConnect Summary

This clinical trial is studying a new tool called SCALA, which is designed to measure lateropulsion in people who have had a stroke. Lateropulsion is a condition where patients have difficulty maintaining their balance and may lean to one side. The trial involves 78 individuals who have experienced a stroke within the last six months, as well as 30 healthy volunteers. Before testing SCALA in the clinic, a group of 20 experts worked together to ensure that the scale accurately reflects the challenges faced by stroke survivors.

If you or a family member have had a stroke and are between the ages of 65 to 74, you may be eligible to participate in this study. Participants will undergo assessments to help researchers understand how well SCALA works. It is important to note that individuals with certain conditions, like severe psychiatric issues or significant balance problems unrelated to stroke, may not qualify. This study aims to improve how we assess balance issues after a stroke, which can ultimately help in better recovery and rehabilitation for patients.

Gender

ALL

Eligibility criteria

• • Inclusion Criteria: All types of stroke, ≤6 months.
• • Exclusion Criteria: postural disorders other than stroke or body geometry disorders (e.g. limb amputation, severe deformity, bone fracture, trunk deformity with deviation of C7 greater than 30mm) interfering with balance, acute vertigo, history of severe psychiatric disease, medical instability, dementia diagnosed, and severe understanding deficits limiting assessments.